Panvascular Medicine Second Edition
Pulmonary Vasculitis
Publication
, Chapter
Orlowsky, E; Kaul, MS; Clair, EWS
January 1, 2015
The systemic vasculitides are rare conditions characterized by inflammation and necrosis of blood vessels. Those with predominately small vessel involvement, such as the ANCA-associated vasculitides (AAV), are the only ones to target the lungs with any regularity.However, these conditions can affect almost any organ system, including the cardiovascular system. Obtaining an accurate diagnosis is crucial before committing a patient to long-term immunosuppressive therapy. The choice of treatment is guided by the organ systems involved, the severity of disease, and the presence of comorbid conditions. Newer treatments are emerging which provide more options in the therapeutic armamentarium.
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Orlowsky, E., Kaul, M. S., & Clair, E. W. S. (2015). Pulmonary Vasculitis. In Panvascular Medicine Second Edition (pp. 4259–4276). https://doi.org/10.1007/978-3-642-37078-6_165
Orlowsky, E., M. S. Kaul, and E. W. S. Clair. “Pulmonary Vasculitis.” In Panvascular Medicine Second Edition, 4259–76, 2015. https://doi.org/10.1007/978-3-642-37078-6_165.
Orlowsky E, Kaul MS, Clair EWS. Pulmonary Vasculitis. In: Panvascular Medicine Second Edition. 2015. p. 4259–76.
Orlowsky, E., et al. “Pulmonary Vasculitis.” Panvascular Medicine Second Edition, 2015, pp. 4259–76. Scopus, doi:10.1007/978-3-642-37078-6_165.
Orlowsky E, Kaul MS, Clair EWS. Pulmonary Vasculitis. Panvascular Medicine Second Edition. 2015. p. 4259–4276.